The illicit drug market has experienced a massive surge in methamphetamine production since 2009 due to the widespread adoption of the phenylacetone manufacturing method. Experts are currently investigating whether the distinct chemical composition of this P2P meth is directly linked to rising rates of schizophrenia and other severe mental health crises.